Showing results (91-100 of 182) with videos related to

Sort By:
Pageof 19
Clinical Genetics|July 18, 2002
Type III hyperlipoproteinema with apolipoprotein E2/2 genotype in JapanM Eto, M Saito, H Nakata, et al.
Bioorganic & Medicinal Chemistry|September 8, 1998
Quantitative structure-activity studies of octopaminergic agonists and antagonists against nervous system of Locusta migratoriaA Hirashima, C Pan, K Shinkai, et al.
Diabetes Research and Clinical Practice|November 1, 1987
Metabolic and morphological changes of the heart in Chinese hamsters (CHAD strain) with spontaneous long-term diabetesM Eto, K Watanabe, M Sekiguchi, et al.
Arthritis and Rheumatism|March 1, 1994
Exacerbation of established collagen-induced arthritis in mice treated with an anti-T cell receptor antibodyT Maeda, I Saikawa, T Hotokebuchi, et al.
The Tohoku Journal of Experimental Medicine|January 1, 1986
Apolipoprotein E phenotypes and plasma lipids in young and middle-aged subjectsM Eto, K Watanabe, Y Iwashima, et al.
Biochemical and Biophysical Research Communications|February 13, 2001
Downregulation of the voltage-dependent calcium channel (VDCC) beta-subunit mRNAs in pancreatic islets of type 2 diabetic ratsY Iwashima, A Abiko, F Ushikubi, et al.
The Journal of Biological Chemistry|July 20, 2001
Activation of myosin light chain phosphatase in intact arterial smooth muscle during nitric oxide-induced relaxationE F Etter, M Eto, R L Wardle, et al.
FEBS Letters|April 5, 2001
Dual Ser and Thr phosphorylation of CPI-17, an inhibitor of myosin phosphatase, by MYPT-associated kinaseJ A MacDonald, M Eto, M A Borman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 20, 2013
A randomized multicenter phase II trial on the efficacy of a hydrocolloid dressing containing ceramide with a low-friction external surface for hand-foot skin reaction caused by sorafenib in patients with renal cell carcinomaN Shinohara, N Nonomura, M Eto, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 15, 1990
Evidence for involvement of clonal anergy in MHC class I and class II disparate skin allograft tolerance after the termination of intrathymic clonal deletionY Tomita, Y Nishimura, N Harada, et al.
Pageof 19